Year

2019

Status

Active

Team

 

Field

Oncology

Location

Oss (NL)

Fund

BGV III

Genase Therapeutics

Genase Therapeutics is developing a small molecule inhibitor against a metabolic target with therapeutic potential in hematologic malignancies and potentially solid tumors.